Overall and central adiposity and risk of contralateral breast cancer: The California Breast Cancer Survivorship Consortium
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Esther M John und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Adiposity, Neoplasms, Second Primary, Obesity, Abdominal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: California Breast Cancer Research Program, NIH HHS, U.S. Department of Defense.
Abstract (Originalsprache)
Data on associations between overall adiposity measured by body mass index (BMI) and risk of contralateral second primary breast cancer (CBC) are inconsistent, and associations with central adiposity have not been investigated. We analyzed harmonized data from six studies for 9479 women with a first primary invasive stage I‐III breast cancer (FBC) diagnosed from 1993 through 2009. Linkage of this cohort with the California Cancer Registry identified 610 CBC, diagnosed more than 180 days after FBC. Multivariable Fine and Gray regression models accounting for competing risks were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) associated with BMI, waist circumference (WC), waist‐to‐height ratio, and body roundness index. In postmenopausal women without use of menopausal hormone therapy (HT) before FBC diagnosis, obesity (vs. normal weight BMI) was associated with a nearly two‐fold higher risk of CBC (HR = 1.89, CI = 1.10–3.24, per 5 kg/m 2 HR = 1.22, CI = 1.07–1.40). No associations with BMI were observed for survivors overall, premenopausal survivors, or postmenopausal survivors with a history of HT use. When stratified by FBC hormone receptor status, a higher risk was limited to postmenopausal women with hormone receptor‐negative FBC without pre‐diagnosis HT use (HR = 2.55, CI = 1.07–6.09, per 5 kg/m 2 HR = 1.36, CI = 1.12–1.65). In survivors overall, larger WC was associated with higher risk of CBC (tertile 3 vs. 1: HR = 1.59, CI = 1.05–2.39, p ‐trend = 0.02) in models adjusted for BMI. Breast cancer survivors with overall or central adiposity may benefit from risk‐reducing weight loss strategies and more frequent surveillance screening after FBC diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.
- Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, California, USA.
- Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
- Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, University of California, Davis, California, USA.
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
- Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Esther M John, Marilyn L Kwan
Förderung
- California Breast Cancer Research Program
- NIH HHS
- U.S. Department of Defense
- NCI NIH HHS
- CDC HHS
- Centers for Disease Control and Prevention
- National Institutes of Health
Zitieren
APA
John, E. M., Koo, J., Keegan, T. H., Gomez, S. L., Ingles, S. A., Kurian, A. W., Neuhausen, S. L., Shariff-Marco, S., Wu, A. H., Cheng, I., & Kwan, M. L. (2026). Overall and central adiposity and risk of contralateral breast cancer: The California Breast Cancer Survivorship Consortium. International Journal of Cancer. https://doi.org/10.1002/ijc.70073
Vancouver
John EM, Koo J, Keegan TH, Gomez SL, Ingles SA, Kurian AW, et al. Overall and central adiposity and risk of contralateral breast cancer: The California Breast Cancer Survivorship Consortium. International Journal of Cancer. 2026. doi:10.1002/ijc.70073
BibTeX
@article{John2026,
author = {John, Esther M and Koo, Jocelyn and Keegan, Theresa H and Gomez, Scarlett L and Ingles, Sue A and Kurian, Allison W and Neuhausen, Susan L and Shariff-Marco, Salma and Wu, Anna H and Cheng, Iona and Kwan, Marilyn L},
title = {Overall and central adiposity and risk of contralateral breast cancer: The California Breast Cancer Survivorship Consortium},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70073}
}
EUVIMED